Skip to main content
Erschienen in: HNO 8/2017

14.07.2017 | Sarkoidose | CME

Manifestationen von Autoimmunerkrankungen in der HNO-Heilkunde

Klassische Symptomatik und diagnostisches Vorgehen

verfasst von: Dr. med. univ. B. Hofauer, A. Chaker, K. Thürmel, A. Knopf

Erschienen in: HNO | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Manifestationen von Autoimmunerkrankungen stellen eine diagnostische Herausforderung dar. Es existieren jedoch verschiedene Erkrankungen dieser Genese, die sich mit typischen Symptomen im Hals-Nasen-Ohren-Bereich manifestieren und daher bei der Differenzialdiagnose berücksichtigt werden sollten. Das Sjögren-Syndrom, verschiedene Vaskulitiden und die Sarkoidose repräsentieren die häufigsten Autoimmunerkrankungen der Hals-Nasen-Ohren-Heilkunde, es werden jedoch auch IgG4-assoziierte Erkrankungen, die rezidivierende Polychondritis und autoimmune Erkrankungen der Schleimhäute beobachtet. Autoimmunerkrankungen können zu Schallempfindungsdefiziten führen. Im Bereich der Schilddrüse können sowohl Hypo- als auch Hyperthyreosen durch Autoimmunerkrankungen verursacht werden. Häufig orientiert sich die Diagnose an entsprechenden Klassifikationskriterien, deren korrekte Anwendung die Abklärung dieser Erkrankungen erleichtern kann.
Literatur
1.
Zurück zum Zitat Knopf A, Bas M, Chaker A et al (2011) Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 50:2029–2034CrossRef Knopf A, Bas M, Chaker A et al (2011) Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 50:2029–2034CrossRef
2.
Zurück zum Zitat Carsons S (2001) A review and update of Sjögren’s syndrome: manifestations, diagnosis, and treatment. Am J Manag Care 7:S433–43PubMed Carsons S (2001) A review and update of Sjögren’s syndrome: manifestations, diagnosis, and treatment. Am J Manag Care 7:S433–43PubMed
3.
Zurück zum Zitat Hofauer B, Bas M, Manour N, Knopf A (2013) Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren’s syndrome. HNO 61:921–927CrossRefPubMed Hofauer B, Bas M, Manour N, Knopf A (2013) Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren’s syndrome. HNO 61:921–927CrossRefPubMed
4.
Zurück zum Zitat Hofauer B, Mansour N, Heiser C et al (2016) Sonoelastographic modalities in the evaluation of salivary gland characteristics in Sjögren’s syndrome. Ultrasound Med Biol 42:2130–2139CrossRefPubMed Hofauer B, Mansour N, Heiser C et al (2016) Sonoelastographic modalities in the evaluation of salivary gland characteristics in Sjögren’s syndrome. Ultrasound Med Biol 42:2130–2139CrossRefPubMed
5.
Zurück zum Zitat Hofauer B, Mansour N, Heiser C, Straßen U, Bas M, Knopf A (2016) Effect of liposomal local therapy on salivary glands in acoustic radiation force impulse imaging in Sjögren’s syndrome. Clin Rheumatol 35:2597–2601CrossRefPubMed Hofauer B, Mansour N, Heiser C, Straßen U, Bas M, Knopf A (2016) Effect of liposomal local therapy on salivary glands in acoustic radiation force impulse imaging in Sjögren’s syndrome. Clin Rheumatol 35:2597–2601CrossRefPubMed
6.
Zurück zum Zitat Knopf A, Hofauer B, Thürmel K et al (2015) Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren’s syndrome. Eur Radiol 25:3027–3034CrossRefPubMed Knopf A, Hofauer B, Thürmel K et al (2015) Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren’s syndrome. Eur Radiol 25:3027–3034CrossRefPubMed
7.
Zurück zum Zitat Brito-Zerón P, Acar-Denizli N, Zeher M et al (2016) Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. doi:10.1136/annrheumdis-2016-209952 Brito-Zerón P, Acar-Denizli N, Zeher M et al (2016) Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. doi:10.​1136/​annrheumdis-2016-209952
8.
Zurück zum Zitat Maldini C, Seror R, Fain O et al (2014) Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken) 66:454–463CrossRef Maldini C, Seror R, Fain O et al (2014) Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken) 66:454–463CrossRef
9.
Zurück zum Zitat Qin B, Wang J, Yang Z et al (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989CrossRefPubMed Qin B, Wang J, Yang Z et al (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989CrossRefPubMed
10.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Hernández-Molina G, Leal-Alegre G, Michel-Peregrina M (2011) The meaning of anti-Ro and anti-La antibodies in primary Sjögren’s syndrome. Autoimmun Rev 10:123–125CrossRefPubMed Hernández-Molina G, Leal-Alegre G, Michel-Peregrina M (2011) The meaning of anti-Ro and anti-La antibodies in primary Sjögren’s syndrome. Autoimmun Rev 10:123–125CrossRefPubMed
12.
Zurück zum Zitat Bijsterveld OP (1969) Diagnostic tests in the Sicca syndrome. Arch Opthalmol 82(1):10–14CrossRef Bijsterveld OP (1969) Diagnostic tests in the Sicca syndrome. Arch Opthalmol 82(1):10–14CrossRef
13.
Zurück zum Zitat Knopf A, Lahmer T, Chaker A et al (2013) Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: a pilot study. Head Neck 35:715–719CrossRefPubMed Knopf A, Lahmer T, Chaker A et al (2013) Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: a pilot study. Head Neck 35:715–719CrossRefPubMed
14.
Zurück zum Zitat Lahmer T, Knopf A, Lanzl I, Heemann U, Thuermel K (2012) Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study. Rheumatol Int 32:2367–2370CrossRefPubMed Lahmer T, Knopf A, Lanzl I, Heemann U, Thuermel K (2012) Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study. Rheumatol Int 32:2367–2370CrossRefPubMed
16.
Zurück zum Zitat Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889CrossRefPubMed Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889CrossRefPubMed
17.
Zurück zum Zitat Gungor S, Ozseker F, Yalcinsoy M et al (2015) Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol 25:174–179CrossRefPubMed Gungor S, Ozseker F, Yalcinsoy M et al (2015) Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol 25:174–179CrossRefPubMed
18.
Zurück zum Zitat Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW (1993) Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 148:483–486CrossRefPubMed Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW (1993) Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 148:483–486CrossRefPubMed
19.
Zurück zum Zitat Rust M, Bergmann L, Kühn T et al (1985) Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosis. Respiration 48:231–236CrossRefPubMed Rust M, Bergmann L, Kühn T et al (1985) Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosis. Respiration 48:231–236CrossRefPubMed
20.
Zurück zum Zitat Müller-Quernheim J (1998) Sarcoidosis: clinical manifestations, staging and therapy (Part II). Respir Med 92:140–149CrossRefPubMed Müller-Quernheim J (1998) Sarcoidosis: clinical manifestations, staging and therapy (Part II). Respir Med 92:140–149CrossRefPubMed
21.
Zurück zum Zitat Hofauer B, Chaker A, Strenger T, Bas M, Mansour N, Knopf A (2016) Swelling of the submandibular and parotid glands: A description of possible differential diagnoses. HNO 64:333–348CrossRefPubMed Hofauer B, Chaker A, Strenger T, Bas M, Mansour N, Knopf A (2016) Swelling of the submandibular and parotid glands: A description of possible differential diagnoses. HNO 64:333–348CrossRefPubMed
22.
23.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed
24.
Zurück zum Zitat Hofauer B, Bas M, Strassen U, Matsuba Y, Mansour N, Knopf A (2014) Liposomal local therapy of sinunasal symptoms in ANCA associated vasculitis. Laryngorhinootologie 93:461–466CrossRefPubMed Hofauer B, Bas M, Strassen U, Matsuba Y, Mansour N, Knopf A (2014) Liposomal local therapy of sinunasal symptoms in ANCA associated vasculitis. Laryngorhinootologie 93:461–466CrossRefPubMed
25.
Zurück zum Zitat Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12:501–505CrossRefPubMed Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev 12:501–505CrossRefPubMed
26.
Zurück zum Zitat Knopf A, Chaker A, Stark T et al (2015) Clinical aspects of granulomatosis with polyangiitis affecting the head and neck. Eur Arch Otorhinolaryngol 272:185–193CrossRefPubMed Knopf A, Chaker A, Stark T et al (2015) Clinical aspects of granulomatosis with polyangiitis affecting the head and neck. Eur Arch Otorhinolaryngol 272:185–193CrossRefPubMed
27.
Zurück zum Zitat Shulman ST, De Inocencio J, Hirsch R (1995) Kawasaki disease. Pediatr Clin North Am 42:1205–1222CrossRefPubMed Shulman ST, De Inocencio J, Hirsch R (1995) Kawasaki disease. Pediatr Clin North Am 42:1205–1222CrossRefPubMed
28.
Zurück zum Zitat Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222PubMed Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222PubMed
29.
Zurück zum Zitat Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128CrossRefPubMed Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128CrossRefPubMed
30.
31.
32.
Zurück zum Zitat Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74:14–18CrossRefPubMed Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74:14–18CrossRefPubMed
33.
Zurück zum Zitat Fatemi G, Fang MA (2013) IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al. Arthritis Rheum 65:2217CrossRefPubMed Fatemi G, Fang MA (2013) IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al. Arthritis Rheum 65:2217CrossRefPubMed
34.
Zurück zum Zitat Cheuk W, Chan JK (2010) IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 17:303–332CrossRefPubMed Cheuk W, Chan JK (2010) IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 17:303–332CrossRefPubMed
35.
Zurück zum Zitat Hao M, Liu M, Fan G, Yang X, Li J (2016) Diagnostic value of serum IgG4 for IgG4-related disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e3785CrossRef Hao M, Liu M, Fan G, Yang X, Li J (2016) Diagnostic value of serum IgG4 for IgG4-related disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e3785CrossRef
36.
Zurück zum Zitat Lahmer T, Knopf A, Treiber M, Heemann U, Thuermel K (2010) Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab. Clin Rheumatol 29:1331–1334CrossRefPubMed Lahmer T, Knopf A, Treiber M, Heemann U, Thuermel K (2010) Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab. Clin Rheumatol 29:1331–1334CrossRefPubMed
37.
Zurück zum Zitat Kent PD, Michet CJ, Luthra HS (2004) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61CrossRefPubMed Kent PD, Michet CJ, Luthra HS (2004) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61CrossRefPubMed
38.
Zurück zum Zitat Hazra N, Dregan A, Charlton J, Gulliford MC, D’Cruz DP (2015) Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology (Oxford) 54:2181–2187 Hazra N, Dregan A, Charlton J, Gulliford MC, D’Cruz DP (2015) Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology (Oxford) 54:2181–2187
39.
40.
Zurück zum Zitat Lahmer T, Treiber M, von Werder A et al (2010) Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev 9:540–546CrossRefPubMed Lahmer T, Treiber M, von Werder A et al (2010) Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev 9:540–546CrossRefPubMed
41.
Zurück zum Zitat Coppola M, Yealy DM (1992) Relapsing polychondritis: an unusual cause of painful auricular swelling. Ann Emerg Med 21:81–85CrossRefPubMed Coppola M, Yealy DM (1992) Relapsing polychondritis: an unusual cause of painful auricular swelling. Ann Emerg Med 21:81–85CrossRefPubMed
42.
Zurück zum Zitat Khan JH, Ahmed I (1999) A case of relapsing polychondritis involving the tragal and the conchal bowl areas with sparing of the helix and the antihelix. J Am Acad Dermatol 41:299–302CrossRefPubMed Khan JH, Ahmed I (1999) A case of relapsing polychondritis involving the tragal and the conchal bowl areas with sparing of the helix and the antihelix. J Am Acad Dermatol 41:299–302CrossRefPubMed
43.
Zurück zum Zitat Cody DT, Sones DA (1971) Relapsing polychondritis: audiovestibular manifestations. Laryngoscope 81:1208–1222CrossRefPubMed Cody DT, Sones DA (1971) Relapsing polychondritis: audiovestibular manifestations. Laryngoscope 81:1208–1222CrossRefPubMed
44.
Zurück zum Zitat Clark LJ, Wakeel RA, Ormerod AD (1992) Relapsing polychondritis – two cases with tracheal stenosis and inner ear involvement. J Laryngol Otol 106:841–844CrossRefPubMed Clark LJ, Wakeel RA, Ormerod AD (1992) Relapsing polychondritis – two cases with tracheal stenosis and inner ear involvement. J Laryngol Otol 106:841–844CrossRefPubMed
45.
Zurück zum Zitat McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55:193–215CrossRef McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55:193–215CrossRef
46.
Zurück zum Zitat Mijovic T, Zeitouni A, Colmegna I (2013) Autoimmune sensorineural hearing loss: the otology-rheumatology interface. Rheumatology (Oxford) 52:780–789CrossRef Mijovic T, Zeitouni A, Colmegna I (2013) Autoimmune sensorineural hearing loss: the otology-rheumatology interface. Rheumatology (Oxford) 52:780–789CrossRef
47.
Zurück zum Zitat McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589CrossRefPubMed McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589CrossRefPubMed
48.
Zurück zum Zitat Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB, Bloch KJ (1994) Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment. JAMA 272:611–616CrossRef Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB, Bloch KJ (1994) Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment. JAMA 272:611–616CrossRef
49.
Zurück zum Zitat George DL, Pradhan S (2009) Idiopathic sensorineural hearing disorders in adults – a pragmatic approach. Nat Rev Rheumatol 5:505–512CrossRefPubMed George DL, Pradhan S (2009) Idiopathic sensorineural hearing disorders in adults – a pragmatic approach. Nat Rev Rheumatol 5:505–512CrossRefPubMed
50.
Zurück zum Zitat Bovo R, Aimoni C, Martini A (2006) Immune-mediated inner ear disease. Acta Otolaryngol 126:1012–1021CrossRefPubMed Bovo R, Aimoni C, Martini A (2006) Immune-mediated inner ear disease. Acta Otolaryngol 126:1012–1021CrossRefPubMed
51.
Zurück zum Zitat Broughton SS, Meyerhoff WE, Cohen SB (2004) Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 34:544–548CrossRefPubMed Broughton SS, Meyerhoff WE, Cohen SB (2004) Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 34:544–548CrossRefPubMed
52.
Zurück zum Zitat Hirose K, Wener MH, Duckert LG (1999) Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 109:1749–1754CrossRefPubMed Hirose K, Wener MH, Duckert LG (1999) Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 109:1749–1754CrossRefPubMed
53.
Zurück zum Zitat García Callejo FJ, Algarra MJ, Martínez Beneyto MP, Orts Alborch MH, Morant Ventura A (2003) Autoimmune identification of sudden hearing loss. Acta Otolaryngol 123:168–171CrossRefPubMed García Callejo FJ, Algarra MJ, Martínez Beneyto MP, Orts Alborch MH, Morant Ventura A (2003) Autoimmune identification of sudden hearing loss. Acta Otolaryngol 123:168–171CrossRefPubMed
54.
Zurück zum Zitat Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499CrossRefPubMed Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499CrossRefPubMed
55.
Zurück zum Zitat Tamai H, Ohsako N, Takeno K et al (1980) Changes in thyroid function in euthyroid subjects with a family history of Graves’ disease: a follow-up study of 69 patients. J Clin Endocrinol Metab 51:1123–1127CrossRefPubMed Tamai H, Ohsako N, Takeno K et al (1980) Changes in thyroid function in euthyroid subjects with a family history of Graves’ disease: a follow-up study of 69 patients. J Clin Endocrinol Metab 51:1123–1127CrossRefPubMed
56.
Zurück zum Zitat Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M (1992) Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 36:211–214CrossRef Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M (1992) Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 36:211–214CrossRef
57.
58.
Zurück zum Zitat Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum 61:600–604CrossRefPubMedPubMedCentral Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum 61:600–604CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Metadaten
Titel
Manifestationen von Autoimmunerkrankungen in der HNO-Heilkunde
Klassische Symptomatik und diagnostisches Vorgehen
verfasst von
Dr. med. univ. B. Hofauer
A. Chaker
K. Thürmel
A. Knopf
Publikationsdatum
14.07.2017
Verlag
Springer Medizin
Erschienen in
HNO / Ausgabe 8/2017
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI
https://doi.org/10.1007/s00106-017-0380-6

Weitere Artikel der Ausgabe 8/2017

HNO 8/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.